Argobio is a French start-up studio dedicated to developing novel therapeutics. It aims to nurture and launch breakthrough biotech companies by creating at least five ambitious therapeutic biotech spinouts over the next five years. The studio is supported by strategic investors including Bpifrance, Kurma Partners, Angelini Pharma, Evotec, and the Institut Pasteur.
Focus Areas
Notable Investments
